Zerbor/iStock via Getty Images
Danaher (DHR) shares fell 10% in premarket trading Tuesday despite the life sciences and diagnostics company reporting second-quarter results that beat Wall Street estimates and raising its full-year earnings guidance.
The company reported adjusted earnings of $1.94 per share on revenue
Source: Seeking Alpha — This article was automatically imported from the source. Read full article at original source →
